ArticleInquiry : a journal of medical care organization, provision and financing
Changes to ACA Individual Insurance Markets After States Leave Healthcare.gov 2016-2023.
Article in Inquiry : a journal of medical care organization, provision and financing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate changes in enrollment, average risk scores, and premiums in the Affordable Care Act individual market after states transitioned from the federally facilitated marketplace (Healthcare.gov) to a state-based marketplace (SBM) between 2018 and 2023. This study employed a retrospective, quasi-experimental design of secondary data using a synthetic difference-in-differences analysis methodology. Our primary data source consisted of individual market risk adjustment summaries from 2016 to 2023. We conducted a synthetic difference-in-differences analysis to evaluate changes in enrolled member months, average premium paid, and state average risk scores in the individual health insurance market. Our treatment group comprised 4 states that transitioned from Healthcare.gov to a state-based marketplace between 2018 and 2023. The comparison group was the 33 states that continuously used Healthcare.gov from 2016 to 2023. States that converted from the FFM, Healthcare.gov, to a state-based marketplace did not experience statistically significant changes in enrollment, premiums paid, or state average risk scores. These results were robust to alternative specifications. The transition to state-based marketplaces in 4 states did not lead to significant changes in the ACA individual market risk pool enrollment, or premiums paid while potentially increasing state policy autonomy. Future policy efforts should explore how states can leverage policy autonomy to improve market outcomes and coverage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.